Latest Breaking News On - Flagship pioneering backed - Page 1 : comparemela.com

Flagship merges two of its biotechs to form cellular microenvironment-focused Sonata

Sonata Therapeutics is developing drugs that reprogram cellular microenvironments to send signals intended to have curative effects. Cancer is the initial focus of the biotech, which Flagship Pioneering formed by combining two of its preclinical portfolio companies.

Inari adds $200m for seed technology expansion

Ginkgo unveils its stock ticker, a biotech venture fund raises $515m, and a unicorn is born

Ginkgo unveils its stock ticker, a biotech venture fund raises $515m, and a unicorn is born By Anissa Gardizy Globe Staff,Updated May 14, 2021, 2 hours ago Email to a Friend Jason Kelly, cofounder and chief executive of Ginkgo Bioworks.Scott Eisen/Bloomberg Here’s a roundup of five local life-science deals and fundraising events that people are talking about this week. Ginkgo Bioworks After announcing a $17.5 billion merger with a SPAC (blank check company) earlier this week, Ginkgo Bioworks on Friday (finally) unveiled its stock ticker as it plans to go public: “DNA.” The biotech explained in a Twitter thread why it chose the ticker, which was first used by Genentech before it was acquired, and why it decided against more obvious trading symbols, such as “GKGO” or “CELL.”

Biotech startup Repertoire adds $189M to expand array of immune medicines

Get the latest industry news first when you subscribe to our daily newsletter. We will never sell or share your information without your consent. See our privacy policy.